Stem Cell Treatment for Heart Damage Progresses to Phase 2 Clinical Trials

The progression of stem cell treatments is the only way to help the heart regenerate its own muscle.

Research teams from Cedars-Sinai Heart Institute and the Minneapolis Heart Institute with funding from CIRM [California Institute for Regenerative Medicine] are moving to Phase 2 Clinical Trials for a treatment that utilizes cardiac stem cells to repair severe heart damage.  The treatment development was led by Eduardo Marbán, a director at the Cedars-Sinai Heart Institute and founder of Capricor.  This groundbreaking treatment involves the injection of stem cells into the coronary artery, which then migrate to the heart and promote the regrowth of healthy heart muscle.

While it was previously thought that the heart was unable to repair itself, researchers have determined that stem cell therapies are a viable method of helping the heart regenerate tissue as a result of a heart attack.  In addition to the treatment developed by Dr. Marbán, there are several stem cell related clinical trials underway to treat damage incurred due to heart failure.

Innovative research such as this demonstrates the integral role stem cell therapies will soon play in cutting edge medical care options.  By banking their own valuable stem cells, families can ensure that they will have access to these emerging therapies in the near future.  To learn more about banking stem cells, please visit www.stemsave.com or call 877-783-6728 (877-StemSave) today.

 

 

To view the full article, click here.

 

 

The Future of Regenerative Medicine is Now™